Houyu Ju

593 total citations
28 papers, 415 citations indexed

About

Houyu Ju is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Houyu Ju has authored 28 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Houyu Ju's work include Cancer Immunotherapy and Biomarkers (8 papers), Head and Neck Cancer Studies (6 papers) and Cancer-related molecular mechanisms research (6 papers). Houyu Ju is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Head and Neck Cancer Studies (6 papers) and Cancer-related molecular mechanisms research (6 papers). Houyu Ju collaborates with scholars based in China, United States and Canada. Houyu Ju's co-authors include Guoxin Ren, Jingzhou Hu, Shuli Liu, Weiya Xia, Yunteng Wu, Hailong Ma, Liming Zhang, Zhiyuan Zhang, Lu Mao and Wei Guo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Science Advances.

In The Last Decade

Houyu Ju

27 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Houyu Ju China 14 214 162 146 69 57 28 415
Longlong Xie China 12 264 1.2× 145 0.9× 119 0.8× 94 1.4× 33 0.6× 27 465
Yuxiang Chen China 10 166 0.8× 154 1.0× 132 0.9× 58 0.8× 42 0.7× 26 367
Chi‐Yao Hsueh China 14 307 1.4× 141 0.9× 233 1.6× 49 0.7× 63 1.1× 48 535
Jadzia Tin-Tsen Chou Poland 6 157 0.7× 150 0.9× 74 0.5× 97 1.4× 70 1.2× 15 421
Haining Li China 11 237 1.1× 141 0.9× 139 1.0× 149 2.2× 110 1.9× 22 482
Haiyan Dai China 11 232 1.1× 75 0.5× 130 0.9× 76 1.1× 28 0.5× 22 374
Aya Matsuda Japan 7 156 0.7× 85 0.5× 109 0.7× 29 0.4× 24 0.4× 18 294
Corey Carter United States 11 147 0.7× 161 1.0× 69 0.5× 71 1.0× 144 2.5× 24 417
Liting You China 9 182 0.9× 152 0.9× 65 0.4× 73 1.1× 63 1.1× 25 412
Roy S India 10 224 1.0× 103 0.6× 77 0.5× 15 0.2× 41 0.7× 21 340

Countries citing papers authored by Houyu Ju

Since Specialization
Citations

This map shows the geographic impact of Houyu Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houyu Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houyu Ju more than expected).

Fields of papers citing papers by Houyu Ju

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Houyu Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houyu Ju. The network helps show where Houyu Ju may publish in the future.

Co-authorship network of co-authors of Houyu Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Houyu Ju. A scholar is included among the top collaborators of Houyu Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Houyu Ju. Houyu Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Wenyi, Zhaoyang Guo, Houyu Ju, et al.. (2025). IL-4-STAT6-induced high Siglec-G/10 expression aggravates the severe immune suppressive tumor microenvironment and impedes the efficacy of immunotherapy in head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 13(6). e011474–e011474. 2 indexed citations
3.
Shi, Chaoji, Houyu Ju, Yunteng Wu, et al.. (2024). Potential role of cyclin-dependent kinase 4/6 inhibitors in the treatment of mucosal melanoma. 3(1). 1 indexed citations
4.
Hui, Rong‐Rong, Houyu Ju, Yunteng Wu, et al.. (2024). The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China. Frontiers in Oncology. 14. 1360657–1360657. 1 indexed citations
5.
Sun, Lulu, Houyu Ju, Chong Wang, et al.. (2023). A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options. Science Advances. 9(43). eadg6686–eadg6686. 24 indexed citations
6.
Ju, Houyu, Yunteng Wu, Yang Liu, et al.. (2023). A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma. SHILAP Revista de lepidopterología. 4(4). e312–e312. 7 indexed citations
7.
Shi, Chaoji, Shengming Xu, Houyu Ju, et al.. (2022). Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line. Cancer Communications. 42(7). 627–647. 7 indexed citations
10.
11.
Ding, Qianshan, Yi Liu, Houyu Ju, et al.. (2020). Reactive cutaneous capillary endothelial proliferation predicted the efficacy of camrelizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma. Medicina oral, patología oral y cirugía bucal. 28(6). 0–0. 4 indexed citations
12.
Liu, Shuli, Yang Wang, Yong Han, et al.. (2020). EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy. Theranostics. 10(23). 10589–10605. 26 indexed citations
13.
Ju, Houyu, Yusheng Lu, Yunteng Wu, et al.. (2020). TLR4 activation leads to anti-EGFR therapy resistance in head and neck squamous cell carcinoma.. PubMed. 10(2). 454–472. 21 indexed citations
15.
Yang, Wen‐Yi, Chunlan Jiang, Weiya Xia, et al.. (2019). Blocking autophagy flux promotes interferon-alpha-mediated apoptosis in head and neck squamous cell carcinoma. Cancer Letters. 451. 34–47. 22 indexed citations
16.
Liu, Shuli, Lei Shi, Yang Wang, et al.. (2018). Stabilization of Slug by NF-κB is Essential for TNF-α -Induced Migration and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cells. Cellular Physiology and Biochemistry. 47(2). 567–578. 35 indexed citations
17.
Jin, Shufang, Hailong Ma, Wenyi Yang, et al.. (2018). Cell division cycle 7 is a potential therapeutic target in oral squamous cell carcinoma and is regulated by E2F1. Journal of Molecular Medicine. 96(6). 513–525. 14 indexed citations
18.
Zhang, Liming, Houyu Ju, Yunteng Wu, et al.. (2018). Long non-coding RNA ANRIL promotes tumorgenesis through regulation of FGFR1 expression by sponging miR-125a-3p in head and neck squamous cell carcinoma.. PubMed. 8(11). 2296–2310. 33 indexed citations
19.
Ju, Houyu, Liming Zhang, Lu Mao, et al.. (2018). A comprehensive genome-wide analysis of the long noncoding RNA expression profile in metastatic lymph nodes of oral mucosal melanoma. Gene. 675. 44–53. 9 indexed citations
20.
Tian, Zhuowei, et al.. (2017). A novel NOTCH3 mutation identified in patients with oral cancer by whole exome sequencing. International Journal of Molecular Medicine. 39(6). 1541–1547. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026